Hims & Hers' stock rebounded from below $14 after a regulatory shock and is now trading above $37 on a diversified growth narrative. Click to learn more.

(NASDAQ:OMCL) (“Omnicell” or the “Company”), a leading healthcare technology provider focused on empowering autonomous medication management, today announced that Nnamdi Njoku has been appointed ...

More than 120 new Florida laws kick in on Wednesday, July 1. Some are minor changes, but some you need to know now.

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the health ...

The Kroger Co. acquisition of Giant Eagle in a billion-dollar deal paves the way for the return of the nation's largest grocery chain to the Northeast Ohio market. The Cincinnati-based supermarket ...

Monday, June 29, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth ...

GLP-1 weight loss drugs just got a lot cheaper for many older Americans. Starting Wednesday, the federal government is offering a selection of the brand name medications to certain Medicare and ...

Software developers are starting to combine the two most successful uses of large language models: coding and customer support.Specifically, they’re using AI to automate the process of turning ...

Objective Hydroxychloroquine (HCQ) is a cornerstone therapy for SLE, reducing flares, organ damage and mortality. However, ...

Cigna’s Evernorth health is investing $100 million to support a new AI-powered program designed to improve how patients ...

Health systems preparing Medicare GLP-1 Bridge program focus on staff education, prior authorization, and workflow coordination ahead of July 1 launch.

The concept of autonomous pharmacies is becoming more popular. This week, startup Queue emerged from stealth, with a goal to ...